Neurogene Inc.’s Post

Designing an end-to-end supply chain in CGT manufacturing is critical to preserve the chain of identity and chain of custody. However, a standardized digital ecosystem is not yet available. How to develop a common approach to overcome the complexities of CGT traceability across the value chain?   Dr. Judith K., PhD together with other BioPhorum experts will give a webinar at this year’s SelectScience Virtual Biopharmaceuticals Summit to further delve into “Standardizing Traceability of Personalized Cell and Gene Therapies”.   She will answer your questions regarding CGT traceability and how the industry may reach digital maturity with standardised processes.   Register now 👇 https://lnkd.in/d6_WWEKt . . . #CellandGene #AdvancedTherapies #Bioprocessing #PharmaManufacturing #Koerber #Pharma #Körber

Turn the pages of our collaborative eBook with Entegris, which is titled 'A practical guide to single-use filtration in biopharma.' What can you learn from this eBook? 🧠 🧪Uncover how pore size and membrane material can be used to tailor filtration processes 🧪Learn how to optimise flow rates to balance efficiency and quality 🧪Discover how single-use filtration systems can boost efficiency, reduce cross-contamination risks and promote sustainable biopharmaceutical manufacturing 🧪Explore how single-use systems can support both medical device and cell and gene therapy processes. Download now to learn more: https://bit.ly/49f0YPE #filteration #singleuse #biopharma

Thoughts on this? >> Discussing Cell And Gene Therapeutics With George Eastwood - The Medicine Maker >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #competitivemarketing #healthcare #pharmaceutical

#Biotech and #Pharma companies are witnessing a sea change in #DiseaseTreatment and, in some cases, the development of cures due to the rapid pace of advances in #CellTherapy and #GeneTherapy. With currently 27 FDA-approved gene and cell therapy products and a plethora of candidates in development and #ClinicalTrials, gene and cell therapies are some of the fastest growing and financially attractive additions to the #Biomed and #Biotech toolkit. #MolecularMedicine #Research #Biotechnology #MedTech #MedTechInnovation #RDI #GenomeEditing #CRISPR #Therapeutics #Pharmaceutical

Thoughts on this? >> Discussing Cell And Gene Therapeutics With George Eastwood - The Medicine Maker >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #pharmaceutical #pharma #biotech

📣 Exciting News! Join us for a groundbreaking webinar series: "Exploring Cutting-Edge Technologies and Modalities in Pharma and Biopharma." 📅 Dates: April 4th, April 16th, April 25th (more to come!) 🔗 Register: https://lnkd.in/gebuzKBk 🔬 Dive into the ever-evolving world of pharmaceutical and biopharmaceutical applications, where we'll explore the latest breakthroughs in MAM, Peptide Mapping, Oligonucleotides, and Gene Therapy. 🌟 Discover how cutting-edge technologies, such as Charged Aerosol Detection (CAD), are revolutionizing the industry, unlocking new possibilities, For all my biopharma customers doing, or considering biopharmaceutical applications including MAM, Peptide Mapping, Oligonucleotides, and Gene Therapy, please do take a look at this webinar series. 🎯 Whether you're a researcher, professional, or simply curious about the future of pharma and biopharma, this webinar series is a must-attend. Don't miss out on the opportunity to stay ahead of the curve! 🔔 Secure your spot by registering now! https://lnkd.in/gebuzKBk #webinar #pharma #biopharma #MAM #peptidemapping #oligonucleotides #genetherapy

Continuous manufacturing (CM, advanced manufacturing) journey in 10 years since the first approval in 2014. Since that time, 10 or more than have been approved for APIs. in the next round, we will see the CM for biologics, cell and gene therapy remains challenging in CM development. Give with intelligent digital twin (Pharma 5.0) and #AI, the CM will sooner or later will be adapted for #Biologcis and #CGT. FDA and EMA (ICH Q13) has been well implemented the guidance for CM, advanced manufacturing.

Discussing Trends in Cell And Gene Therapeutics - The Medicine Maker >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #competitivemarketing #pharma #healthcare

Are you interested in meeting and forming lasting connections with gene therapy regulators and the leading regulatory personnel across biopharma? Join the Gene Therapy Regulatory Affairs Summit to connect with 80+ regulatory leaders in the biopharma industry. Gain insights on navigating the hottest topics limiting regulatory progress and invest in your regulatory success. Attending companies include AstraZeneca, Pfizer, Regeneron. BridgeBio, Omega Therapeutics, Spark Therapeutics, Inc., 4D Molecular Therapeutics, Ultragenyx, Adverum Biotechnologies, Solid Biosciences, and more! Don't miss out on the opportunity to form lasting connections and advance your regulatory expertise. Register before Friday, October 27 and save up to $1,050 on your attendance: https://ter.li/sqviat #GeneTherapy #RegulatoryAffairs #Biopharma #RegulatoryLeaders #regulation

Global 𝐏𝐥𝐚𝐬𝐦𝐢𝐝 𝐃𝐍𝐀 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 Size, Share, Trends, Growth and Forecast 2023-2030-Pragma Market Research and Business Consulting Global Plasmid DNA Manufacturing market is projected to reach 𝐔𝐒$ 𝟏𝟔𝟕.𝟏 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 in 2029, increasing from 𝐔𝐒$ 𝟏𝟐𝟎.𝟏 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 in 2022, with the 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟒.𝟗% during the period of 2023 to 2029. 𝐁𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐲: COBRA BIOLOGICS LIMITED, Richter-Helm BioLogics, Eurogentec, Cell and Gene Therapy Catapult, VGXI, PlasmidFactory GmbH - The Minicircle Company, KANEKA CORPORATION, Nature Technology Corporation , Waisman Biomanufacturing, FUJIFILM Diosynth Biotechnologies, LAKE PHARMA 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐛𝐲 𝐓𝐲𝐩𝐞: HQ Grade Plasmid DNA GMP Grade Plasmid DNA Non-GMP Grade Plasmid DNA 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: Cancers Inherited Disorders Viral Infections Others #PlasmidManipulation #DNATechniques #MolecularBiology #GeneticEngineering #DNAManipulation #MolecularCloning #GeneticManipulation #RecombinantDNA #GeneEditing #VectorConstruction